TrialAddiction (Abingdon, England)2017

PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trial.

Joy M Schmitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.